By the end of 2017, CTS has secured three source plasma partners and continues to seek additional partners in the plasma industry in order to continue to diversify CTS’s revenue stream.
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...